| Literature DB >> 6315230 |
A Coune, J P Sculier, J Frühling, P Stryckmans, C Brassinne, G Ghanem, C Laduron, G Atassi, J M Ruysschaert, J Hildebrand.
Abstract
Five patients with advanced multiresistant neoplasms were infused with NSC-251635 (a water-insoluble antimitotic agent) entrapped in egg yolk lecithin, cholesterol, and stearylamine liposomes. The maximum volume injected was 400 ml containing 8 g of lipids, ie, a dose of 135 mg/kg of body weight. Overall tolerance of the treatment was excellent. This study indicates that liposomes may be used safely as carriers for the iv administration of water-insoluble drugs to humans.Entities:
Mesh:
Substances:
Year: 1983 PMID: 6315230
Source DB: PubMed Journal: Cancer Treat Rep ISSN: 0361-5960